Treatment with laquinimod 0.5 mg showed consistent effects on remission ( 48.3 % ( CI 31 % to 66 % ) vs 15.9 % ( CI 9 % to 27 % ) ) , response 100 ( 55.2 % ( CI 37 % to 71 % ) vs 31.7 % ( CI 22 % to 44 % ) ) and response 70 ( 62.1 % ( CI 44 % to 77 % ) vs 34.9 % ( CI 24 % to 47 % ) ) versus placebo .